Alvotech (NASDAQ:ALVOW – Get Free Report) is anticipated to announce its resultson Wednesday, May 6th. Analysts expect the company to announce earnings of ($0.0470) per share and revenue of $112.3860 million for the quarter.
Alvotech Stock Performance
Shares of ALVOW stock opened at $0.28 on Tuesday. Alvotech has a 12-month low of $0.15 and a 12-month high of $3.00. The firm’s 50 day moving average is $0.29 and its 200 day moving average is $0.61.
Alvotech Company Profile
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Featured Articles
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
